Jame Abraham, MD, FACP(@jamecancerdoc) 's Twitter Profileg
Jame Abraham, MD, FACP

@jamecancerdoc

Prof & Chair Dept. of Heme & Oncology @ClevelandClinic @NRGonc Deputy Editor @ASCOPost and @JCOOP_ASCO Tweets are mine. No act of #Kindness is ever wasted!

ID:311474165

linkhttp://my.clevelandclinic.org/staff_directory/staff_display?DoctorID=18395 calendar_today05-06-2011 14:28:28

15,7K Tweets

10,9K Followers

1,9K Following

Follow People
Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo

DESTINY-Breast06 will be presented on 6/2 at by my friend & mentor of many years G Curigliano MD PhD. The trial, announced to be positive, may have a major impact on treatment sequencing and on the definition of HER2. Set your alarm clocks early on Sunday, make sure not to miss it.

DESTINY-Breast06 will be presented on 6/2 at #ASCO24 by my friend & mentor of many years @curijoey. The trial, announced to be positive, may have a major impact on treatment sequencing and on the definition of HER2. Set your alarm clocks early on Sunday, make sure not to miss it.
account_circle
Rabi Hanna(@RabiHannaMD) 's Twitter Profile Photo

What an Amazing event to raise fund for Cleveland Clinic Children’s Derby Soiree . Many thanks for our strong 💪 team who make miracles happen every day through and innovative care. Thank you 🙏 Eddie DeBartolo , Joseph Montana and all donors who make this possible.

What an Amazing event to raise fund for #Research @CleClinicKids Derby Soiree . Many thanks for our strong 💪 team who make miracles happen every day through #Research and innovative care. Thank you 🙏 Eddie DeBartolo , @JoeMontana and all donors who make this possible.
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

The ASCENT study out on npj Journals
Showing that sacituzumab govitecan 💉offers:

✅significant improvements📈 in PFS and OS compared to standard chemotherapy🧪 in specific subgroups of metastatic triple-negative patients

➡️Manageable safety profile, affirming its…

The ASCENT study out on @Nature_NPJ Showing that sacituzumab govitecan 💉offers: ✅significant improvements📈 in PFS and OS compared to standard chemotherapy🧪 in specific subgroups of metastatic triple-negative #BreastCancer patients ➡️Manageable safety profile, affirming its…
account_circle
Jame Abraham, MD, FACP(@jamecancerdoc) 's Twitter Profile Photo

Design and Implementation of an Opt-Out, End-to-End, Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine | JCO Oncology Practice ASCO OncoAlert ascopubs.org/doi/pdf/10.120…

Design and Implementation of an Opt-Out, End-to-End, Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine | @JCOOP_ASCO @ASCO @OncoAlert ascopubs.org/doi/pdf/10.120…
account_circle
ClevelandClinicNews(@CleClinicNews) 's Twitter Profile Photo

Each year the Kay Yow Cancer Fund awards a grant in the Women's Basketball Final Four host city.
We are profoundly grateful for their support of our Cancer Institute's community outreach program, allowing us to help more people gain access to early screening services.

Each year the @KayYowFund awards a grant in the Women's Basketball Final Four host city. We are profoundly grateful for their support of our Cancer Institute's community outreach program, allowing us to help more people gain access to early screening services. #NCAATournament
account_circle
Jame Abraham, MD, FACP(@jamecancerdoc) 's Twitter Profile Photo

We are looking for outstanding oncologists to lead breast cancer, lung cancer and other programs at ⁦Cleveland Clinic Abu Dhabi⁩ ⁦Cleveland Clinic! Exciting chance of being part of a world class global healthcare team! ⁩ If interested please send a DM to me or ⁦Stephen Grobmyer⁩ !!

We are looking for outstanding oncologists to lead breast cancer, lung cancer and other programs at ⁦@CCAD⁩ ⁦@ClevelandClinic! Exciting chance of being part of a world class global healthcare team! ⁩ If interested please send a DM to me or ⁦@grobmys⁩ !!
account_circle